PRINCETON, N.J. — Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces that its chief executive officer, Edward J. Quilty, highlighted the rapid growth of MEDIHONY^[2]® Dressings with medical grade Manuka (Leptospermum) Honey, and the rewarding relationship between Derma Sciences and Comvita Limited in a presentation at Comvita’s annual shareholders’ meeting in New Zealand yesterday. MEDIHONEY is the leading brand of medical grade honey products and is one of the fastest-growing moist wound healing wound dressings in the field of advanced wound care, with a sales growth rate exceeding 30% annually…